Graphene-based biosensors incorporated in arrays of microneedles are emerging as an alternative to hypodermic needles and could be the next generation of blood sampling devices.
Guideomics to live up to the promise of biotechnology for precision medicine of brain diseases
Personalized medicine for diseases that affect the central nervous system requires renewed focus on visualising the behaviour of drugs in the brain.
Joining forces to build realistic living tissue
Hybridizing biofabrication processes will lead us to superior “living” tissue and organ substitutes that can be used to treat patients in lieu of donor grafts and metal and plastic devices.
Earlier diagnosis and better treatment for type 1 diabetes
Nanotechnology is poised to revolutionize the diagnosis and treatment of patients with type 1 diabetes.
Combining nanoparticles with new X-ray technologies could revolutionize imaging diagnosis
A new study explores how metal nanoparticles designed for new X-ray imaging technologies can improve the diagnosis of diseases, as well as understand the underlying cellular processes.
Shedding light on inflammation
Cutting-edge fluorine-19 imaging of inflammation extends the frontiers of MRI.
Nanomedicine and drug delivery systems: The cutting edge of modern healthcare
Micro- and nanoparticle-based drug delivery systems are revolutionizing medicine, from minimizing the toxicity of therapeutics to improving their efficacy.
Predicting the behavior of macromolecules
Researchers at Houston Methodist Research Institute discuss how quantitative, non-invasive imaging can aid in developing novel tools for diagnosis and therapy.
Does the dusk of “old-school antibiotics” mean the dawn of antimicrobial nanomaterials?
Antibiotic-resistant bacteria are becoming a major global threat. Novel antibacterial nanomaterials offer a solution.
A new, inhaled siRNA therapeutic option for asthma
A nanocarrier that can deliver siRNA into the lungs is investigated for the treatment of severe asthma and other lung diseases.